Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells

Erik L. Bao, Satish K. Nandakumar, Xiaotian Liao, Alexander G. Bick, Juha Karjalainen, Marcin Tabaka, Olga I. Gan, Aki S. Havulinna, Tuomo Kiiskinen, Caleb A. Lareau, Aitzkoa Lopez de Lapuente Portilla, Bo Li, Connor A. Emdin, Veryan Codd, Christopher P. Nelson, Christopher J. Walker, Claire Churchhouse, Albert de la Chapelle, Daryl E. Klein, Björn Nilsson, Peter W.F. Wilson, Kelly Cho, Saiju Pyarajan, J. Michael Gaziano, Nilesh J. Samani, FinnGen, Aarno Palotie, Mark J. Daly, Pharmaceutical companies, Howard J. Jacob, Athena Matakidou, Heiko Runz, Sally John, Robert M. Plenge, Mark I. McCarthy, Julie Hunkapiller, Meg Ehm, Dawn Waterworth, Caroline S. Fox, Anders Mälarstig, Kathy Klinger, Kathy Call, Tomi P. Mäkelä, Jaakko Kaprio, Petri Virolainen, Kari Pulkki, Terhi Kilpi, Markus Perola, Jukka Partanen, Anne Pitkäranta, Riitta Kaarteenaho, Seppo Vainio, Kimmo Savinainen, Veli‐Matti Kosma, Urho M. Kujala, Other experts and non-voting members, Outi Tuovila, Minna Hendolin, Raimo Pakkanen, Pharmaceutical companies, Jeff Waring, Bridget Riley‐Gillis, Athena Matakidou, Heiko Runz, Jimmy Z. Liu, Shameek Biswas, Julie Hunkapiller, Dawn Waterworth, Meg Ehm, Dorothée Diogo, Caroline S. Fox, Anders Mälarstig, Catherine Marshall, Xinli Hu, Kathy Call, Kathy Klinger, Matthias Gossel, Samuli Ripatti, Johanna Schleutker, Markus Perola, Mikko Arvas, Olli Carpén, Reetta Hinttala, Johannes Kettunen, Reijo Laaksonen, Arto Mannermaa, Urho M. Kujala, Other experts and non-voting members, Outi Tuovila, Minna Hendolin, Raimo Pakkanen, Neurology group, Hilkka Soininen, Valtteri Julkunen, Anne M. Remes, Reetta Kälviäinen, Mikko Hiltunen, Jukka Peltola, Pentti J. Tienari, Juha O. Rinne